scispace - formally typeset
K

Katia Aquilano

Researcher at University of Rome Tor Vergata

Publications -  97
Citations -  13501

Katia Aquilano is an academic researcher from University of Rome Tor Vergata. The author has contributed to research in topics: Mitochondrion & Adipose tissue. The author has an hindex of 41, co-authored 86 publications receiving 11184 citations.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Immune evasion in cancer: Mechanistic basis and therapeutic strategies

TL;DR: The advances made toward understanding the basis of cancer immune evasion are discussed, the efficacy of various therapeutic measures and targets that have been developed or are being investigated to enhance tumor rejection are summarized and some natural agents and phytochemicals merit further study.
Journal ArticleDOI

Glutathione: new roles in redox signaling for an old antioxidant

TL;DR: This review will be focused on the role of GSH in cell signaling by analysing the more recent advancements about its capability to modulate nitroxidative stress, autophagy, and viral infection.
Journal ArticleDOI

Broad targeting of resistance to apoptosis in cancer.

TL;DR: This review provides a roadmap for the design of successful anti-cancer strategies that overcome resistance to apoptosis for better therapeutic outcome in patients with cancer.
Journal ArticleDOI

Sustained proliferation in cancer: Mechanisms and novel therapeutic targets

TL;DR: Natural compounds found to inhibit one or more pathways that contribute to proliferation have been found and will be very important for identifying signaling pathways and molecular targets that may provide early diagnostic markers and/or critical targets for the development of new drugs or drug combinations that block tumor formation and progression.